Amneal Pharmaceuticals, Inc. (AMRX): Shareholders' Equity
-$70.79M
As of 2025-12-31
$33.02M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$70.79M | n/m | 2026-02-27, Balance as of period end |
| 2024-12-31 | -$109.27M | n/m | 2026-02-27, Balance as of period end |
| 2023-12-31 | $19.78M | -93.4% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $298.42M | -17.2% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $360.34M | +18.8% | 2023-03-03, Balance as of period end |
| 2020-12-31 | $303.27M | +30.7% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $232.01M | -54.0% | 2021-03-01, Balance as of period end |
| 2018-12-31 | $504.75M | n/a | 2020-03-02, Balance as of period end |
| 2017-12-31 | $0 | n/a | 2018-03-09, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $9.71B | -6.1% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.14B | -25.3% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $2.94B | -32.0% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $4.32B | +5.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.55B | +7.4% |
Compare AMRX, UTHR, BMRN, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗